ZAHARA II Risk Calculator

Clinical calculation support · Verify results before clinical use

Maternal Cardiac Risk Assessment

Select each clinical feature present according to the ZAHARA risk model.

0.00Total score

History of arrhythmias

Prior clinically documented arrhythmia.

+1.50 points

Cardiac medication before pregnancy

Use of cardiovascular medication before pregnancy.

+1.50 points

NYHA functional class ≥ II

NYHA class II, III, or IV before pregnancy.

+0.75 points

Left heart obstruction

Model criterion: peak gradient >50 mmHg or aortic valve area <1.0 cm².

+2.50 points

Moderate/severe systemic AV valve regurgitation

Moderate or severe regurgitation of the systemic atrioventricular valve.

+0.75 points

Moderate/severe pulmonary AV valve regurgitation

Moderate or severe regurgitation of the subpulmonary atrioventricular valve.

+0.75 points

Mechanical valve prosthesis

Presence of a mechanical prosthetic heart valve.

+4.25 points

Cyanotic congenital heart disease

Corrected or uncorrected cyanotic congenital heart disease.

+1.00 points
0.00ZAHARA score
Estimated maternal cardiovascular complication risk
Lowest risk category
2.9% reported event rate for score 0–0.50
Clinical interpretationUse this estimate as one component of pre-pregnancy and pregnancy cardiovascular risk assessment.

These are cohort-derived category event rates, not individualized probabilities calibrated for every cardiac diagnosis. ZAHARA was developed in women with congenital heart disease; applicability to other populations is limited.

About the ZAHARA Risk Score

The ZAHARA score was developed to estimate maternal cardiovascular complications in women with congenital heart disease. It is a weighted clinical score, not the linear-predictor equation present in the uploaded source file.

Predictors and weights

PredictorPoints
History of arrhythmias1.50
Cardiac medication before pregnancy1.50
NYHA class ≥ II before pregnancy0.75
Left heart obstruction2.50
Moderate/severe systemic AV valve regurgitation0.75
Moderate/severe pulmonary AV valve regurgitation0.75
Mechanical valve prosthesis4.25
Cyanotic congenital heart disease, corrected or uncorrected1.00

Reported maternal event rates

Total scoreReported event rate
0–0.502.9%
0.51–1.507.5%
1.51–2.5017.5%
2.51–3.5043.1%
>3.5070.0%

References

Drenthen W, Boersma E, Balci A, et al.Predictors of pregnancy complications in women with congenital heart disease. European Heart Journal. 2010;31(17):2124–2132.https://doi.org/10.1093/eurheartj/ehq200
European Society of Cardiology.ESC Guidelines on the management of cardiovascular diseases during pregnancy. European Heart Journal. 2011;32:3147–3197.https://doi.org/10.1093/eurheartj/ehr218

Important scope limitation

ZAHARA was derived for congenital heart disease and should not replace contemporary multidisciplinary assessment, lesion-specific risk assessment, or guideline-based pregnancy risk classification. Confirm the intended model name and citation before publishing under the “ZAHARA II” label.

Clinical disclaimer: This calculator is an educational decision-support aid and must not be used as the sole basis for clinical decisions. Pregnancy risk assessment should incorporate the underlying cardiac lesion, ventricular function, pulmonary hypertension, aortopathy, prior events, medications, and specialist cardio-obstetric evaluation. The event rates shown are those reported for the ZAHARA score and may not generalize to all populations.